Pancreatic Cancer Research

ResearcherSecond Military Medical UniversityActive in the last 2 years

Mengwen Hu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-7480-6432; OpenAlex author ID A5000137112, A5082650437. Sources: OpenAlex.

Their work

Papers
3 (first author 0, last author 1)
Trials
0
Grants
0
Labs led
0
Collaborators
8
Papers, trials and grants by year

2022: 1 paper · 2023: 1 paper · 2024: none · 2025: none · 2026: 1 paper

Papers 3

  1. CEP55 Drives Pancreatic Cancer Progression by Suppressing Ferroptosis. Last author DOI 10.1002/biof.70084↗
  2. Correction: Felsenstein M. et al. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? J. Clin. Med. 2022… Co-author DOI 10.3390/jcm12216947↗
  3. Perineural Invasion in Pancreatic Ductal Adenocarcinoma (PDAC): A Saboteur of Curative Intended Therapies? Co-author DOI 10.3390/jcm11092367↗

Closest collaborators

The 8 strongest of 8 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. S. Zhang · 1 shared paper, 2026 · strength 0.43
  2. Christian Benzing · 2 shared papers, 2022–2023 · strength 0.28
  3. Bruno Valentin Sinn · 2 shared papers, 2022–2023 · strength 0.28
  4. Thomas Malinka · 2 shared papers, 2022–2023 · strength 0.28
  5. Lea Timmermann · 2 shared papers, 2022–2023 · strength 0.28
  6. Matthäus Felsenstein · 2 shared papers, 2022–2023 · strength 0.28
  7. Uli Fehrenbach · 2 shared papers, 2022–2023 · strength 0.28
  8. Uwe Pelzer · 2 shared papers, 2022–2023 · strength 0.28

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.